ALPHA & OMEGA SEMICONDUCTOR (AOSL) Fundamental Analysis & Valuation

NASDAQ:AOSL • BMG6331P1041

Current stock price

43.08 USD
-0.35 (-0.81%)
At close:
43.01 USD
-0.07 (-0.16%)
After Hours:

This AOSL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. AOSL Profitability Analysis

1.1 Basic Checks

  • AOSL had negative earnings in the past year.
  • In the past year AOSL had a positive cash flow from operations.
  • In multiple years AOSL reported negative net income over the last 5 years.
  • AOSL had a positive operating cash flow in each of the past 5 years.
AOSL Yearly Net Income VS EBIT VS OCF VS FCFAOSL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • AOSL has a worse Return On Assets (-10.30%) than 73.91% of its industry peers.
  • AOSL's Return On Equity of -12.61% is on the low side compared to the rest of the industry. AOSL is outperformed by 72.17% of its industry peers.
Industry RankSector Rank
ROA -10.3%
ROE -12.61%
ROIC N/A
ROA(3y)-3.1%
ROA(5y)6.38%
ROE(3y)-3.88%
ROE(5y)11.4%
ROIC(3y)N/A
ROIC(5y)N/A
AOSL Yearly ROA, ROE, ROICAOSL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

1.3 Margins

  • AOSL has a worse Gross Margin (22.47%) than 73.91% of its industry peers.
  • In the last couple of years the Gross Margin of AOSL has remained more or less at the same level.
  • AOSL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.52%
GM growth 5Y0.92%
AOSL Yearly Profit, Operating, Gross MarginsAOSL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

5

2. AOSL Health Analysis

2.1 Basic Checks

  • AOSL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AOSL has been increased compared to 1 year ago.
  • The number of shares outstanding for AOSL has been increased compared to 5 years ago.
  • The debt/assets ratio for AOSL has been reduced compared to a year ago.
AOSL Yearly Shares OutstandingAOSL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
AOSL Yearly Total Debt VS Total AssetsAOSL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • AOSL has an Altman-Z score of 5.91. This indicates that AOSL is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 5.91, AOSL perfoms like the industry average, outperforming 51.30% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that AOSL is not too dependend on debt financing.
  • The Debt to Equity ratio of AOSL (0.00) is better than 67.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.91
ROIC/WACCN/A
WACC12.85%
AOSL Yearly LT Debt VS Equity VS FCFAOSL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • AOSL has a Current Ratio of 3.44. This indicates that AOSL is financially healthy and has no problem in meeting its short term obligations.
  • AOSL has a Current ratio (3.44) which is comparable to the rest of the industry.
  • AOSL has a Quick Ratio of 2.01. This indicates that AOSL is financially healthy and has no problem in meeting its short term obligations.
  • AOSL has a Quick ratio of 2.01. This is comparable to the rest of the industry: AOSL outperforms 43.48% of its industry peers.
Industry RankSector Rank
Current Ratio 3.44
Quick Ratio 2.01
AOSL Yearly Current Assets VS Current LiabilitesAOSL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

4

3. AOSL Growth Analysis

3.1 Past

  • AOSL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.43%.
  • Measured over the past years, AOSL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.39% on average per year.
  • Looking at the last year, AOSL shows a small growth in Revenue. The Revenue has grown by 2.92% in the last year.
  • AOSL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.41% yearly.
EPS 1Y (TTM)-131.43%
EPS 3Y-63.57%
EPS 5Y-24.39%
EPS Q2Q%-277.78%
Revenue 1Y (TTM)2.92%
Revenue growth 3Y-3.62%
Revenue growth 5Y8.41%
Sales Q2Q%-6.29%

3.2 Future

  • AOSL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.75% yearly.
  • AOSL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.38% yearly.
EPS Next Y-390.55%
EPS Next 2Y-104.81%
EPS Next 3Y66.75%
EPS Next 5YN/A
Revenue Next Year-2.01%
Revenue Next 2Y2.12%
Revenue Next 3Y6.38%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AOSL Yearly Revenue VS EstimatesAOSL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
AOSL Yearly EPS VS EstimatesAOSL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

1

4. AOSL Valuation Analysis

4.1 Price/Earnings Ratio

  • AOSL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year AOSL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AOSL Price Earnings VS Forward Price EarningsAOSL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AOSL is valued a bit cheaper than 66.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 48.48
AOSL Per share dataAOSL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • A more expensive valuation may be justified as AOSL's earnings are expected to grow with 66.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-104.81%
EPS Next 3Y66.75%

0

5. AOSL Dividend Analysis

5.1 Amount

  • No dividends for AOSL!.
Industry RankSector Rank
Dividend Yield 0%

AOSL Fundamentals: All Metrics, Ratios and Statistics

ALPHA & OMEGA SEMICONDUCTOR

NASDAQ:AOSL (5/1/2026, 8:09:43 PM)

After market: 43.01 -0.07 (-0.16%)

43.08

-0.35 (-0.81%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Industry Strength93.17
Industry Growth91.93
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners77.38%
Inst Owner Change0.32%
Ins Owners17.17%
Ins Owner Change2.19%
Market Cap1.28B
Revenue(TTM)685.88M
Net Income(TTM)-103.28M
Analysts77.78
Price Target22.44 (-47.91%)
Short Float %5.84%
Short Ratio2.81
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.32%
Min EPS beat(2)-88.24%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)72.66%
Min EPS beat(4)-88.24%
Max EPS beat(4)296.08%
EPS beat(8)6
Avg EPS beat(8)58.77%
EPS beat(12)9
Avg EPS beat(12)101.76%
EPS beat(16)11
Avg EPS beat(16)75.81%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)-0.99%
Revenue beat(4)2
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)2.65%
Revenue beat(8)2
Avg Revenue beat(8)-0.39%
Revenue beat(12)3
Avg Revenue beat(12)-0.4%
Revenue beat(16)5
Avg Revenue beat(16)-0.67%
PT rev (1m)0%
PT rev (3m)-9.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-176.92%
EPS NY rev (1m)0%
EPS NY rev (3m)-248.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.42%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.87
P/FCF N/A
P/OCF 194.13
P/B 1.57
P/tB 1.57
EV/EBITDA 48.48
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.48
Fwd EYN/A
FCF(TTM)-1.39
FCFYN/A
OCF(TTM)0.22
OCFY0.52%
SpS23.05
BVpS27.51
TBVpS27.47
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -10.3%
ROE -12.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.47%
FCFM N/A
ROA(3y)-3.1%
ROA(5y)6.38%
ROE(3y)-3.88%
ROE(5y)11.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.52%
GM growth 5Y0.92%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.13
Cap/Depr 77.12%
Cap/Sales 6.99%
Interest Coverage N/A
Cash Conversion 29.02%
Profit Quality N/A
Current Ratio 3.44
Quick Ratio 2.01
Altman-Z 5.91
F-Score6
WACC12.85%
ROIC/WACCN/A
Cap/Depr(3y)128.04%
Cap/Depr(5y)168.75%
Cap/Sales(3y)8.98%
Cap/Sales(5y)11.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.43%
EPS 3Y-63.57%
EPS 5Y-24.39%
EPS Q2Q%-277.78%
EPS Next Y-390.55%
EPS Next 2Y-104.81%
EPS Next 3Y66.75%
EPS Next 5YN/A
Revenue 1Y (TTM)2.92%
Revenue growth 3Y-3.62%
Revenue growth 5Y8.41%
Sales Q2Q%-6.29%
Revenue Next Year-2.01%
Revenue Next 2Y2.12%
Revenue Next 3Y6.38%
Revenue Next 5YN/A
EBIT growth 1Y-117.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year368.82%
EBIT Next 3Y132.51%
EBIT Next 5YN/A
FCF growth 1Y54.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.28%
OCF growth 3Y-48.63%
OCF growth 5Y-13.79%

ALPHA & OMEGA SEMICONDUCTOR / AOSL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALPHA & OMEGA SEMICONDUCTOR?

ChartMill assigns a fundamental rating of 3 / 10 to AOSL.


What is the valuation status of ALPHA & OMEGA SEMICONDUCTOR (AOSL) stock?

ChartMill assigns a valuation rating of 1 / 10 to ALPHA & OMEGA SEMICONDUCTOR (AOSL). This can be considered as Overvalued.


Can you provide the profitability details for ALPHA & OMEGA SEMICONDUCTOR?

ALPHA & OMEGA SEMICONDUCTOR (AOSL) has a profitability rating of 2 / 10.